Cite
MLA Citation
S.H.J Hageman et al.. “Predicted lifetime therapy benefit guided treatment effectively reduces residual cardiovascular risk in patients with symptomatic atherosclerotic disease.” European heart journal, vol. 41, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100117807355.0x000029